We are live on ! Find out more
LAB icon

Standard BioTools
LAB

68 hedge funds and large institutions have $54.2M invested in Standard BioTools in 2022 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 18 increasing their positions, 22 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

28% more capital invested

Capital invested by funds: $42.5M → $54.2M (+$11.7M)

27% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 11

9.5% more ownership

Funds ownership: 49.12% → 58.62% (+9.5%)

5% more funds holding

Funds holding: 65 → 68 (+3)

18% less repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 22

65% less call options, than puts

Call options by funds: $37K | Put options by funds: $107K

Holders
68
Holders Change
+3
Holders Change %
+4.62%
% of All Funds
1.09%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
14
Increased
18
Reduced
22
Closed
11
Calls
$37K
Puts
$107K
Net Calls
-$70K
Net Calls Change
-$18K

Top Buyers

1
HBWM
Hollow Brook Wealth Management
New York
+$861K
2
HighTower Advisors
HighTower Advisors
Illinois
+$257K
3
Morgan Stanley
Morgan Stanley
New York
+$209K
4
JCP
Jennifer C. Price
+$146K
5
BCM
Bridgeway Capital Management
Texas
+$61.6K

Top Sellers

1
BlackRock
BlackRock
New York
-$712K
2
Primecap Management
Primecap Management
California
-$382K
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$293K
4
PVI
Pura Vida Investments
New York
-$278K
5
E
Ergoteles
New York
-$220K
Name Holding Trade Value Shares
Change 		Change in
Stake
IP
26
Intellectus Partners
California
$78.1K -$20.2K -16,400 -20%
Royal Bank of Canada
27
Royal Bank of Canada
Ontario, Canada
$70K -$81 -66 -0.1%
BCPWM
28
Bradley & Co Private Wealth Management
Florida
$58.5K – – –
Goldman Sachs
29
Goldman Sachs
New York
$53K -$1.23K -996 -2%
Group One Trading
30
Group One Trading
Illinois
$52.7K +$14.9K +12,127 +37%
Susquehanna International Group
31
Susquehanna International Group
Pennsylvania
$50.5K +$53.1K +43,137 New
Two Sigma Advisers
32
Two Sigma Advisers
New York
$45.6K -$43.8K -35,600 -48%
XT
33
XTX Topco
Cayman Islands
$42.9K -$154K -125,226 -77%
UBS Group
34
UBS Group
Switzerland
$38K +$16.5K +13,365 +70%
Commonwealth Equity Services
35
Commonwealth Equity Services
Massachusetts
$35K +$18K +14,630 +95%
SEI Investments
36
SEI Investments
Pennsylvania
$32.4K -$1.42K -1,156 -4%
TRCT
37
Tower Research Capital (TRC)
New York
$28K +$29K +23,523 New
Citadel Advisors
38
Citadel Advisors
Florida
$25.7K +$12.3K +9,973 +83%
Prudential Financial
39
Prudential Financial
New Jersey
$25.5K – – –
E
40
Ergoteles
New York
$21.4K -$220K -178,578 -91%
MHC
41
Meyer Handelman Company
New York
$20.5K – – –
ECM
42
ExodusPoint Capital Management
New York
$20K +$20.8K +16,895 New
VF
43
Virtu Financial
New York
$19K +$19.9K +16,167 New
EGM
44
Engineers Gate Manager
New York
$16.7K -$3.82K -3,103 -18%
LCS
45
Levin Capital Strategies
New York
$16K – – –
Cerity Partners
46
Cerity Partners
New York
$14.7K +$224 +182 +1%
IA
47
IFP Advisors
Florida
$9K -$494 -401 -21%
Fidelity Investments
48
Fidelity Investments
Massachusetts
$7.62K +$8.02K +6,515 New
Osaic Holdings
49
Osaic Holdings
Arizona
$7K -$8.54K -6,936 -56%
CWM
50
CarsonAllaria Wealth Management
Illinois
$5K – – –
1
2
3 4

LAB Hedge Fund Activity: Q4 2022 in Review

68 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q4 2022, worth a combined $54.2M — up 28% from $42.5M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new LAB positions and 11 closed out — a net gain of 3 holders — while 18 added to existing stakes and 22 trimmed.

The largest buyer was Hollow Brook Wealth Management, opening a new position worth an estimated $861K. The largest seller was BlackRock, cutting an estimated $712K.

  • 68 institutional investors held Standard BioTools (LAB) as of Q4 2022, up from 65 in Q3 2022.
  • Funds reported $54.2M of Standard BioTools stock for Q4 2022, up 28% quarter-over-quarter.
  • 14 funds opened new Standard BioTools positions in Q4 2022 and 11 closed out, a net change of +3 holders.
  • The largest Standard BioTools buyer in Q4 2022 was Hollow Brook Wealth Management, an estimated $861K added.
  • The largest Standard BioTools seller in Q4 2022 was BlackRock, an estimated $712K sold.

Based on aggregated 13F filings for Q4 2022.